Renal hypoplasia, defined as abnormally small kidneys with normal morphology and reduced nephron number, is a common cause of pediatric renal failure and adult-onset disease. Genetic studies ...

The locus coeruleus is emerging as a major new area of research interest, with many important functions such as regulating ...

Vitalone confirmed the company raised its adjusted EPS guidance to a range of $32.55 to $32.95 for fiscal 2025, representing 19%-20% year-over-year growth. Management raised full-year guidance for ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

CFO Shawn Vadala reported Q4 sales of $1.045 billion, representing a 12% increase in both local currency and U.S. dollars. Adjusted operating profit rose 25%, with a margin of 33.7%, up 360 basis ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Happening Thursday, February 13, 2025, 4:30 – 7:00 p.m. at the Barr Road Sports Complex, 213 Barr Road, Lexington, LEXPO is ...

Premature birth and low birth weight disrupt kidney development substantially, which leads to an increased risk of acute kidney injury, chronic kidney disease and hypertension. Broader awareness ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/19.DnqOsaYJ.js ...

Brent Jones; Chief Financial Officer, Executive Vice President; Avantor Inc Hello everybody, and a warm welcome to Avantor's fourth-quarter 2024 earnings call. My name is Emily and I coordinating your ...

Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the pricing ...